Growth hormone levels decreased from 13.5 ± 3.1 ... The authors concluded that long-term treatment with somatostatin analogs is effective and well tolerated.

Although the mechanism of hypothyroidism after growth hormone replacement therapy remains ... deiodination of T 4 to T 3 and secretion of somatostatin, thereby blocking TSH secretion from the ...

Growth hormone (GH) acts on many tissues throughout ... the researchers found that male mice lacking the GH receptor in a group of somatostatin-expressing neurons displayed increased anxiety.

Inhibiting the hormone somatostatin may be a new treatment strategy to prevent dangerous blood glucose drops in type 1 diabetes. This has been shown by a study conducted at, among others ...

Pasireotide, a new panreceptor analog, might control clinical symptoms and hormone release in patients resistant to standard somatostatin analog therapy. mTOR and tyrosine kinase inhibitors may ...

May need to adjust antidiabetic agents. Octreotide acetate is a potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Like somatostatin, it also suppresses LH response to ...